Position in GRFS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$239,955
+$228,535 QoQ
Shares Held
33,892
+2280.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 164 holders
Holding Since
Mar 2022
9 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $3,483,940,248 across 16 Drug Manufacturers - General names. GRFS ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
781,929 | $937,869,169 | |
| 2 | JNJ |
Johnson & Johnson
|
2,675,500 | $679,496,724 | |
| 3 | ABBV |
AbbVie Inc.
|
1,621,115 | $407,937,369 | |
| 4 | AZN |
Astrazeneca PLC
|
2,033,587 | $385,608,756 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,578,024 | $331,276,081 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
4,215,423 | $242,892,664 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,070,731 | $135,276,147 | |
| 8 | PFE |
Pfizer Inc
|
5,482,863 | $132,027,333 |
All Filings in GRFS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $239,955 | 33,892 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $11,420 | 1,424 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $13,314 | 1,424 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $13,416 | 1,347 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $12,014 | 1,329 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $362 | 51 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $379 | 51 | Shares | Defined | 2025-02-13 | |
| 2022-06-30 | $657,664 | 55,359 | Shares | Defined | 2022-07-29 | |
| 2022-03-31 | $809,587 | 69,314 | Shares | Defined | 2022-05-05 | |
| No filing history on record for this holder in this stock. | ||||||